Clinical trial
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid…
NCT00228605 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00228605 |
|---|---|
| Title | Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain |
| Official title | An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis |
| Intervention type | Drug |
| Interventions | OraVescent Fentanyl |
| Enrollment | 500 |
| Start date | Mar 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: